ROLE FOR THERAPEUTIC DRUG MONITORING IN ASSESSING SECONDARY LOSS OF RESPONSE TO MAINTENANCE ANTI-TNFA THERAPY IN INFLAMMATORY BOWEL DISEASE.

(1) AMNCH Tallaght,Gastroenterology Trinity Academic Gastroenterology Group (TAGG),Dublin,Ireland

(2) Trinity College Dublin,School of Medicine,Dublin,Ireland

(3) Trinity College Dublin,Trinity Academic Gastroenterology Group,Dublin,Ireland



This item was part of UEG Week 2017

This item can be cited as: United European Gastroenterology Journal 2017; 5 (Supplement 1)